Vast Therapeutics, a clinical-stage life science company developing nitric oxide-based medicines for serious lung diseases, ...

Researchers have found that an effective way of treating the coronavirus behind the 2003 SARS epidemic also works on the closely related SARS-CoV-2 virus, the culprit in the ongoing COVID-19 pandemic.

An in vitro study finds that nitric oxide may suppress SARS-CoV-2, the virus that causes COVID-19. The researchers suggest that inhaled nitric oxide may be an effective treatment for the disease. All ...

KNOW Bio, a biotechnology startup in Research Triangle Park, has joined the raft of companies around the world trying to see if their existing technology might have some effect in the fight against ...

Inhaled nitric oxide gas widens blood vessels in the lungs and is used to treat severe cardio-pulmonary conditions in newborns and adults. A recent multicenter international phase II clinical trial ...

New research led by Devang K. Sanghavi of the Mayo Clinic in Florida, USA, suggests pre-intubation use of nitric oxide for patients with COVID-19–related hypoxemic respiratory may help reduce patients ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--SaNOtize Research & Development Corp., (“SaNOtize”), a Canadian anti-infective-focused therapeutics company, today announced an oversubscribed $24 million ...

Add Yahoo as a preferred source to see more of our stories on Google. "Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." First things first: nitric oxide ...

Researchers at Uppsala University have found that an effective way of treating the coronavirus behind the 2003 SARS epidemic also works on the closely related SARS-CoV-2 virus, the culprit in the ...